SRPT: Sarepta Therapeutics to Share Clinical Update for 30 mg/kg arm of MOMENTUM Study for SRP-5051, Its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy

New alert via PocketInfo for SRPT:

Sarepta Therapeutics to Share Clinical Update for 30 mg/kg arm of MOMENTUM Study for SRP-5051, Its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy

Press Releases: http://investorrelations.sareptatherapeutics.com/phoenix.zhtml?c=64231&p=irol-news&nyo=0
SEC Filings: http://investorrelations.sareptatherapeutics.com/phoenix.zhtml?c=64231&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8